Could A $775 Million Roche-Blueprint Deal Unseat Eli Lilly In Cancer?Investors Business Daily • 07/14/20
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancersGlobeNewsWire • 07/14/20
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered CancersPRNewsWire • 07/14/20
New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia AGlobeNewsWire • 07/13/20
Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancerGlobeNewsWire • 07/13/20
Exclusive: EU reaches deals with Roche, Merck for supply of COVID-19 drugs - sourceReuters • 07/08/20
FDA approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancerGlobeNewsWire • 06/29/20
Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia AGlobeNewsWire • 06/29/20
Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorderGlobeNewsWire • 06/29/20
Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithmGlobeNewsWire • 06/26/20
Roche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpointsGlobeNewsWire • 06/19/20
Roche's Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With PneumoniaThe Motley Fool • 06/19/20
Roche’s Tecentriq in combination with chemotherapy (including Abraxane) meets primary endpoint of improved pathological complete response, regardless of PD-L1 status, as initial treatment for people with early triple-negative breast cancerGlobeNewsWire • 06/18/20
Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020GlobeNewsWire • 06/13/20
Roche announces 2-year risdiplam data from SUNFISH and new data from JEWELFISH in infants, children and adults with spinal muscular atrophy (SMA)GlobeNewsWire • 06/12/20